Uncategorised - European Medical Journal

Contraceptive Counselling: A Discussion for Healthcare Professionals

This material has been developed and fully funded by Gedeon Richter. This is intended for healthcare professionals only (including UK)…

The Future of Food Allergy: Hugh Sampson

What initially drew you to the field of allergy and immunology, and how did your focus come to centre on food allergic disorders? I got…

Menthol Cigarettes Carry Higher Mortality Risk Compared to Non-Menthol

Smoking menthol-flavored cigarettes is associated with higher mortality risks compared to non-menthol cigarettes according to a new study.

Managing PTLD in Pediatric Liver Transplants

The significant concern of Epstein-Barr virus (EBV) in pediatric liver transplant recipients due to its strong association with post-transplant lymphoproliferative disorder (PTLD) has been explored in a recently published study.

RA Drugs Show Promise Despite Kidney Issues

Explore the efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease, highlighting potential risks like deep vein thrombosis.

Dupilumab Shows Cardiometabolic Benefits in Atopic Dermatitis

A recent global retrospective cohort study has demonstrated that dupilumab, a monoclonal antibody used to treat atopic dermatitis (AD), offers a favorable cardiometabolic safety profile compared to traditional systemic agents such as methotrexate and cyclosporine.

Eli Lilly plans record $50bn US manufacturing investment

The company’s investment will expand its US manufacturing footprint and is the largest investment of its kind in history.

Copper Dysregulation Identified as Key Driver of Ageing

Increased copper activity contributes to ageing-related oxidative stress, but targeted chelation therapy may offer a promising intervention.

Teleneurorehabilitation: A Safe, Effective Alternative for Parkinson’s Treatment

Teleneurorehabilitation safely improves Parkinson’s symptoms and quality of life, offering a viable alternative to in-person therapy.

Cycling JAK Inhibitors More Effective Than Switching to Biologics in Rheumatoid Arthritis

New research suggests that cycling between JAK inhibitors may be more effective than switching to biologic DMARDs in rheumatoid arthritis patients who do not initially respond to JAKis.